1,116 results on '"Esteban, Rafael"'
Search Results
2. Modeling of the Interaction of Plasma-Polymerized Pyrrole with Immunoglobulin M (IgM) by Biocomputational Tools
3. Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years
4. Integrating viral hepatitis management into the emergency department: A further step towards viral hepatitis elimination
5. Obstruction level detection of sewer videos using convolutional neural networks
6. mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels)
7. HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
8. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
9. FRI-427 Chronic hepatitis delta with normal ALT and hepatitis D viremia: unravelling its natural history
10. Modeling of the Interaction of Plasma-Polymerized Pyrrole with Immunoglobulin M (IgM) by Biocomputational Tools
11. Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D
12. Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective‐prospective study.
13. Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response
14. #2917 Desensitization techniques in ABO-incompatible renal transplantation: efficacy and analysis of complications
15. Evaluación del valor clínico y económico de sofosbuvir/velpatasvir (SOF/VEL) en pacientes con hepatitis C crónica en España durante los últimos 5 años
16. Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy
17. Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B
18. Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B
19. Etiologies and Features of Acute Viral Hepatitis in Spain
20. Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitis
21. Documento de consenso de la Asociación Española para el Estudio del Hígado sobre el tratamiento de la infección por el virus de la hepatitis B (2020)
22. Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide
23. Assessing the rate of non‐linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK‐B study
24. Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts
25. Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis
26. Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
27. Multicentric Study on Total Pancreatectomies
28. Estudio multicéntrico nacional sobre pancreatectomías totales
29. Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy
30. Assessing the rate of non‐linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK‐B study.
31. Impact of hepatitis D reflex testing on the future disease burden: A modelling analysis
32. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events
33. Hepatitis C in Patients With Minimal or No Hepatic Fibrosis : The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes
34. Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis
35. Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
36. Quantitative characterization of hepatitis delta virus genome edition by next-generation sequencing
37. Tenofovir Alafenamide Fumarate : A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection
38. Concomitant use of proton pump inhibitors and Sofosbuvir/Velpatasvir: evidence from randomized clinical trials and real-world data
39. HBV and HDV interaction and variability in a superinfection mouse model: role of type I interferon
40. New and easy strategy for mass screening for hepatitis C in leisure spaces
41. Systematic screening for hepatitis B at emergency department and linkage to care in Barcelona, Spain
42. Impact of the anti-HDV reflex testing on the reduction of hepatitis D burden in Spain
43. Patients with hepatitis B and D are more often linked to medical care than patients with hepatitis C
44. Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials
45. An electronic alert system increases screening for hepatitis B and C and improves management of patients with haematological disorders
46. Anti-HBc impacts on the risk of hepatitis B reactivation but not on survival of solid-organ transplant recipients
47. Surface plasmon excitation in fiber-optics sensors: a novel theoretical approach.
48. Is generative artificial intelligence the next step toward a personalized hemodialysis?
49. Securing wider EU commitment to the elimination of hepatitis C virus
50. Modelos de machine learning para la optimización en tiempo real de la dosificación de coagulante en la ETAP de Sant Joan Despí
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.